Skip to main content

Table 1 FGFR fusion partners

From: Fibroblast growth factor receptor fusions in cancer: opportunities and challenges

Gene

5′-Gene

3′-Gene

Tumor type

Case reported

FGFR1

ZNF198

FGFR1

Hematopoietic neoplasm

Not reported

BCR

FGFR1

Hematopoietic neoplasm

Not reported

FOP1

FGFR1

Hematopoietic neoplasm

Not reported

CNTRL

FGFR1

Hematopoietic neoplasm

Not reported

BAG4

FGFR1

Non-small cell lung cancer

1/220

RHOT1

FGFR1

Breast cancer

1/1019

NSD3

FGFR1

Breast cancer

2/1019

FGFR1

HOOK3

Gastrointestinal stromal tumor

1/186

FGFR1

TACC1

Glioblastoma

1/97

FGFR1

ZNF703

Breast cancer

1/24

FGFR1

NTM

Bladder urothelial carcinoma

1/295

FGFR1

ADAM18

Breast cancer

1/1019

FGFR1

SLC20A2

Lung adenocarcinoma

1/487

FGFR2

FGFR2

PPHLN1

Intrahepatic cholangiocarcinoma

20/122

FGFR2

BICC1

Intrahepatic cholangiocarcinoma

2/66

FGFR2

AHCYL

Intrahepatic cholangiocarcinoma

7/66

FGFR2

CCAR2

Lung squamous cell carcinoma

1/220

FGFR2

USP10

Ovarian cancer

1/400

FGFR2

OFD1

Thyroid carcinoma

1/494

FGFR3

FGFR3

TACC3

Glioblastoma

6/158

FGFR3

TACC3

Low-grade glioma

1/266

FGFR3

TACC3

Non-small cell lung cancer

5/220

FGFR3

TACC3

Bladder cancer

3/121

FGFR3

TACC3

Head and neck squamous cancer

2/300

FGFR3

TACC3

Lung squamous cell carcinoma

4/2375

FGFR3

BAIAP2L1

Bladder cancer

2/46

FGFR3

TPRG1

Head and neck squamous cancer

1/300

FGFR3

ELAVL3

Low-grade glioma

1/266

FGFR3

AES

Prostate adenocarcinoma

1/178